Trial Profile
A Randomized, Single-Dose, Two-Period,Two-Sequence Crossover Study Assessing Bioequivalence of Oral Formulations of Anastrozole in Healthy Chinese Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 May 2018
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Pharmacokinetics
- 02 May 2018 New trial record